Here are the 424B prospectus supplements from AEVEX Corp. (AVEX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow AVEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AVEX filings page.
AEVEX Corp. is offering 8,000,000 shares of Class A common stock, consisting of 5,726,157 shares offered by AEVEX and 2,273,843 shares being sold by the Selling Securityholders. The public offering price is $27.00 per share, with total gross proceeds of $216,000,000. AEVEX expects to use its net proceeds to purchase Class B common stock and LLC Units of Athena Technology Solutions Holdings, LLC, while AEVEX will not receive proceeds from the Selling Securityholders’ resale; underwriting discounts and commissions apply. The prospectus discloses a potential substantial Tax Receivable Agreement payment obligation and provides pro forma figures linked to exchanges of LLC Units.
AEVEX Corp. is conducting an initial public offering of 16,000,000 shares of Class A common stock at an initial public offering price of $20.00 per share. The offering is structured as an Up-C and will result in AEVEX Corp. becoming a holding company whose principal asset will be LLC Units of Athena Technology Solutions Holdings, LLC ("Holdings LLC"). AEVEX Corp. expects net proceeds to AEVEX Corp. of approximately $300.8 million before expenses, which it will use to acquire newly issued LLC Units of Holdings LLC; Holdings LLC will apply proceeds to repay outstanding indebtedness and for general corporate purposes. The company will enter into a Tax Receivable Agreement requiring AEVEX Corp. to make cash payments to TRA Rights Holders; the prospectus states these payments "will be substantial and could materially affect our liquidity." The underwriters may purchase an additional 2,400,000 shares and have reserved up to 5% of the offering for a reserved share program. Preliminary ranges for the quarter ended March 31, 2026 include estimated revenue of $200.0M–$208.0M and estimated Adjusted EBITDA of $33.5M–$36.4M, compared to prior-period figures disclosed in the prospectus.